Human chorionic gonadotropin (hCG) is a hormone primarily produced by the syncytiotrophoblasts of the placenta during pregnancy, playing a critical role in maintaining pregnancy by stimulating the corpus luteum to produce progesterone.
hCG exists in various forms, including intact hCG (composed of alpha and beta subunits) and free β-hCG (the beta subunit not bound to the alpha subunit). Testing both glycosylated hCG and free β-hCG is crucial for comprehensive pregnancy monitoring and diagnosis.
Free β-hCG is particularly important in early prenatal screenings for chromosomal abnormalities such as Down syndrome and in diagnosing and monitoring certain cancers, including trophoblastic and germ cell tumors.
Accurate measurement of free β-hCG alongside glycosylated hCG enhances diagnostic accuracy, supports effective clinical decision-making, and provides essential insights into pregnancy health and potential complications.
Human chorionic gonadotropin (hCG) is a hormone produced by trophoblast tissue in early embryos, which later becomes part of the placenta. It plays a crucial role in stimulating the corpus luteum to produce progesterone, essential for maintaining pregnancy.
Measuring hCG levels helps identify normal and pathological pregnancies, monitor post-abortion recovery, and detect certain cancers such as choriocarcinoma and germ cell tumors.
Composed of alpha and beta subunits, hCG is present in various forms in serum and urine during pregnancy, primarily metabolized by the liver and excreted in urine.
Serum hCG tests are highly sensitive and specific, while urine tests, though less sensitive, are convenient and quick.
Accurate hCG measurement is vital in pregnancy monitoring and cancer detection.
hCG can refer to a few different isomers.
For example, intact hCG consists of both the alpha and beta subunits together. This is the complete hormone as it is produced by the placenta.
Beta-hCG can refer to either the intact hormone (including the alpha and beta subunits) or specifically the beta subunit.
In contrast, free β-hCG refers specifically to the beta subunit that is not bound to the alpha subunit. It circulates freely in the blood, and is used in certain prenatal screenings.
Like intact hCG, free hCG is primarily produced by placental trophoblast cells during pregnancy.
Free hCG can be measured separately from intact hCG in maternal serum.
Human chorionic gonadotropin (hCG) is primarily produced by the syncytiotrophoblastic cells of the placenta during pregnancy.
It plays a critical role in the maintenance of pregnancy by stimulating the corpus luteum to produce progesterone, which is essential for sustaining the endometrial lining. Additionally, smaller amounts of hCG are produced in the pituitary gland, liver, and colon.
The regulation of hCG production involves several physiological mechanisms.
During early pregnancy, hCG levels rise rapidly, doubling approximately every 24 hours in the first eight weeks. This rapid increase is crucial for signaling the corpus luteum to continue progesterone production.
The peak of hCG levels typically occurs around 10 weeks of gestation, after which the levels decrease and stabilize until term.
hCG is primarily metabolized by the liver, with about 20% excreted in the urine. The beta subunit is degraded in the kidney to form a core fragment, which is detected in urine hCG tests.
Overall, the production and regulation of hCG are tightly controlled to ensure the proper development and maintenance of pregnancy, as well as to support various physiological functions in non-pregnant states and certain pathological conditions.
hCG consists of two subunits: alpha and beta. The alpha subunit is common to other hormones such as luteinizing hormone (LH), follicle-stimulating hormone (FSH), and thyroid-stimulating hormone (TSH). The beta subunit, which is unique to hCG, is what distinguishes it from these other hormones.
Measurements of human chorionic gonadotropin (hCG) synthesized by trophoblast cells are crucial for pregnancy assessment and monitoring, and they may also hold value in other conditions. [6.]
Both trophoblastic and non-trophoblastic malignancies also produce various hCG molecules.
In urine and serum of pregnant women and cancer patients, fifteen different forms of hCG, including regular hCG, hyperglycosylated hCG, and the hyperglycosylated free β-subunit, have been identified. [6.]
These different forms are clinically useful for distinguishing between normal and pathological pregnancies as well as cancers.
Free β-hCG can be detected by point-of-care tests such as the iSTAT β-hCG. This helps in diagnosing pregnancies of unknown location (PUL), where determining the viability and location of the pregnancy is crucial.
The presence and levels of free β-hCG can aid in distinguishing between ongoing intrauterine pregnancies, failing intrauterine pregnancies, ectopic pregnancies, and persistent PULs.
Free β-hCG is an essential marker for early detection of chromosomal abnormalities.
Elevated levels of free β-hCG are associated with an increased risk of Down syndrome (trisomy 21), while decreased levels are associated with trisomy 18 (Edward syndrome) and trisomy 13 (Patau syndrome).
The screening is performed between 11 + 0 to 13 + 6 weeks of gestation. It combines measurements of serum free β-hCG and PAPP-A, along with maternal age and nuchal translucency thickness, to identify pregnancies at risk of chromosomal abnormalities.
Certain malignancies, such as trophoblastic cancers (e.g., hydatidiform mole, choriocarcinoma) and germ cell tumors, can produce free β-hCG. Measuring free β-hCG can help in diagnosing and monitoring these cancers.
High hCG levels early in pregnancy (>100,000 mIU/mL) can indicate conditions like complete hydatidiform mole. Precise hCG measurements are crucial for assessing tumor mass, treatment success, and disease recurrence. [1., 3.]
The detection of elevated levels of free β-hCG can indicate gestational trophoblastic disease and other conditions where there is ectopic production of hCG, providing a critical diagnostic tool in oncology.
It may also indicate some non-trophoblastic cancers including testicular cancer, ovarian cancer, bladder cancer, and various other extra-uterine cancers. [1., 3.]
Elevated hCG levels in non-pregnant individuals, particularly those over 55 and those with relevant clinical symptoms, can indicate the presence of these cancers. [1., 3.]
The hCG and free hCG test is available in urine and blood.
Serum tests for hCG are immunometric assays that are highly sensitive and specific. They can detect free beta-hCG levels as low as 1 to 2 mIU/mL.
Urine tests, although less sensitive, are convenient, affordable, and provide quick results. However, they typically detect hCG levels starting at 20 to 50 mIU/mL and may not detect hyperglycosylated hCG, which predominates in early pregnancy.
Serum hCG testing is performed in laboratories, while urine testing can be done at home or in point-of-care settings. Both tests have potential for false positives and negatives due to various factors such as dilution, the presence of blood or proteins, and the "hook effect."
The hook effect is a false-negative result that occurs when extremely high levels of hCG overwhelm the ability of the test to detect it accurately. This can happen in advanced molar pregnancies, multiple gestations, [4., 7.]
Special preparation is typically not required for a blood test. A first-morning urine sample is typically recommended for urine tests, especially early in pregnancy.
Optimal levels of free hCG depend on the individual’s health history, concerns, and desires regarding pregnancy.
In the absence of illness or malignancy, elevated hCG levels often indicate an early pregnancy.
As part of first- or second-trimester screening for a genetic condition, elevated free hCG may indicate the presence of certain genetic disorders including Downs Syndrome, which requires further assessment.
Elevated free hCG levels in a nonpregnant person, a person over 55, or a man indicate a need for additional screening for a trophoblastic or non-trophoblastic malignancy.
Low levels of hCG indicate that the individual is not pregnant.
In pregnant people with unexpectedly low levels of free hCG, assessment for miscarriage, ectopic pregnancy, and certain genetic disorders including Edwards syndrome or Patau syndrome is warranted.
In addition to free hCG, several other biomarkers are closely related and can provide complementary information in various clinical settings.
Total hCG refers to the sum of free hCG and hCG bound to other proteins in the serum or plasma.
While free hCG is more specific for certain conditions such as gestational trophoblastic diseases, total hCG can be useful in monitoring overall hCG levels during pregnancy and in the diagnosis of other conditions like germ cell tumors.
Free hCG (Human Chorionic Gonadotropin) is a hormone produced by the placenta during pregnancy.
Free hCG refers to the unbound beta subunit of the hormone that circulates in the blood. It is used in various medical tests, including pregnancy tests and certain cancer screenings.
Free hCG plays several roles, primarily related to pregnancy, including:
Free hCG is measured through blood or urine tests. The most common methods include:
Elevated levels of free hCG can indicate:
Low levels of free hCG can indicate:
Management of abnormal free hCG levels depends on the underlying cause:
Lifestyle changes cannot directly affect free hCG levels. However, maintaining a healthy lifestyle during pregnancy can support overall maternal and fetal health. This includes:
For more information about free hCG and related conditions, consider consulting:
Click here to view testing options and order testing for hCG.
[1.] Betz D, Fane K. Human Chorionic Gonadotropin. [Updated 2023 Aug 14]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK532950/
[2.] Nwabuobi C, Arlier S, Schatz F, Guzeloglu-Kayisli O, Lockwood CJ, Kayisli UA. hCG: Biological Functions and Clinical Applications. Int J Mol Sci. 2017 Sep 22;18(10):2037. doi: 10.3390/ijms18102037. PMID: 28937611; PMCID: PMC5666719.
[3.] Ogino MH, Tadi P. Physiology, Chorionic Gonadotropin. [Updated 2022 Nov 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556118/
[4.] Point-of-care testing for human chorionic gonadotrophin (hCG) — NIHR Community Healthcare MIC. www.community.healthcare.mic.nihr.ac.uk. https://www.community.healthcare.mic.nihr.ac.uk/reports-and-resources/horizon-scanning-reports/point-of-care-testing-for-human-chorionic-gonadotrophin-hcg
[5.] Shiefa S, Amargandhi M, Bhupendra J, Moulali S, Kristine T. First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome. Indian J Clin Biochem. 2013 Jan;28(1):3-12. doi: 10.1007/s12291-012-0269-9. Epub 2012 Oct 12. PMID: 24381414; PMCID: PMC3547446.
[6.] Szczerba A, Białas P, Pięta PP, Jankowska A. hCG - related molecules and their measurement. Ginekol Pol. 2016;87(1):65-70. doi: 10.17772/gp/60981. PMID: 27306471.
[7.] Winder AD, Mora AS, Berry E, Lurain JR. The "hook effect" causing a negative pregnancy test in a patient with an advanced molar pregnancy. Gynecol Oncol Rep. 2017 Jun 7;21:34-36. doi: 10.1016/j.gore.2017.06.008. PMID: 28653031; PMCID: PMC5475266.